China’s innovation in translational medicine: rethinking early-stage clinical development

Key Points

• Innovation in translational medicine enhances clinical development processes and outcomes, impacting public health.
• Key evidence shows significant advancements in regulatory frameworks and therapeutic strategies in China.
• Observational analysis across multiple institutions highlights effective methods for integrating biomarkers into clinical trials.
• This approach may enable faster access to novel therapeutics but requires further validation across diverse settings.